Moderna signs contract to supply Covid-19 booster vaccines to the US
The initial 66 million vaccine doses are anticipated to be supplied this year.

The initial 66 million vaccine doses are anticipated to be supplied this year.
The company intends to supply the vaccines from its 230,000ft2 Sainte-Foy, Quebec facility.
The notice says that Janssen intends to not purchase the minimum quantity of product mentioned in the initial agreement.
The company sought manufacturing and sales approval for S-217622 from Japan’s PMDA in February this year.
Through the deal extension, ER-Kim gained exclusive rights to commercialise QRX003 in six additional countries.
A total of 54 million doses of the vaccine will be delivered to COVAX this year under the initial agreement.
GSK plans to supply the doses of sotrovimab by 17 December to enable broader access of the therapy to patients.
Through LenzMAP, hospitalised Covid-19 patients can get access to lenzilumab by their doctors.
Thank you for subscribing to Pharmaceutical Technology